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Cardiovascular  (CV)  disease  is  the  leading  cause  of  death  in
the Portuguese  population,  accounting  for  29.8%  of  deaths
in 2016,  mainly  due  to  stroke  (10.6%)  and  coronary  heart
disease (CHD)  (10.5%).1,2
Hypertension  is  the  single  most  important  risk  factor  for
CV disease.  In  Portugal,  its  prevalence  is  high  (approximately
42%), as  demonstrated  in  previous  studies,3,4 increases  with
age, and  is  usually  associated  with  other  risk  factors  and
comorbidities.
The PRECISE  study5 (PREvalence  of  Cardiovascular  RIsk
FactorS in  patients  with  high  blood  pressure  in  Portuguese
primary health  care  centers)  was  carried  out  at  primary
health care  centers  (PHCCs)  with  the  primary  objective  of
determining the  proportion  of  patients  with  hypertension
(defined as  blood  pressure  [BP]  ≥140/90  mmHg)  who  pre-
sented other  cardiovascular  risk  factors  and  specific  types
of target  organ  damage  such  as  left  ventricular  hypertro-
phy (LVH)  detected  by  ECG  and  proteinuria.  Among  the
secondary objectives  was  establishing  the  prevalence  of
cardiovascular risk  factors,  including  smoking,  hypercholes-
terolemia, obesity,  type  2  diabetes,  physical  inactivity,
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r proteinuria.
The study  enrolled  2848  patients,  with  a  mean  age  of
5.8±11.0 years  (60.8%  female),  63.9%  of  whom  were  in  the
0-79 age  group.
In  a  well-written  paper  with  informative  infographics,  the
uthors report  that  81.7%  of  these  patients  had  three  or
ore risk  factors  in  addition  to  hypertension,  and  although
lmost all  (98%)  were  on  antihypertensive  drugs,  only  43%
ad controlled  BP,  and  in  those  with  three  or  more  risk
actors or  comorbidities,  only  36%  had  normal  BP,  with  no
ignificant differences  between  the  sexes.  This  low  rate  of
P control  worsened  with  age  and  with  greater  number  of
oncomitant cardiovascular  risk  factors.
Since  about  two-thirds  of  the  patients  in  this  study  were
ver 60  years  of  age,  it  would  also  have  been  valuable  to
nalyze the  prevalence  and  impact  on  rate  of  BP  control  of
ther comorbidities  such  as  atrial  fibrillation,  sleep  apnea
nd dementia,  which  are  particularly  common  in  the  elderly
nd raise  additional  therapeutic  issues  that  may  also  have
ontributed to  the  low  rate  of  BP  control.
The  authors  conclude  that  the  high  prevalence  of  car-
iovascular risk  factors,  in  particular  hypercholesterolemia
82.1%) and  sedentarism  (71.4%),  and  the  persistence  of
ncontrolled hypertension  despite  medical  therapy,  consti-
ute a  challenge  that  requires  the  organization  of  structured
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nterdisciplinary  teams  that  can  prioritize  and  address  the
esired therapeutic  goals.
The  results  of  this  study  are  in  line  with  four  other  stud-
es also  performed  in  Portuguese  PHCCs.3,4,6,7 These  portray
he real  world  of  the  PHCC  patient  population,  which  has
 high  prevalence  of  cardiovascular  risk  factors,  including
yslipidemia and  metabolic  syndrome,  and  is  increasingly
lder (Portugal  has  the  second  oldest  population  in  the  Euro-
ean Union),  with  high  rates  of  physical  disability  resulting
n fewer  years  of  healthy  life.
It  is  imperative  to  reverse  the  low  rate  of  control  of
ardiovascular risk  factors,  which  ultimately  results  in  high
ates of  cardiovascular  morbidity  and  mortality.
To  fulfill  this  unmet  need,  it  is  important  to  adopt  more
ailored approaches  for  the  management  of  hypertension,
ased on  assessment  of  patients’  overall  cardiovascular  risk,
nd to  determine  the  most  appropriate  pharmacological  and
on-pharmacological strategies,  with  particular  emphasis  on
romoting more  active  lifestyles,  as  advocated  by  the  latest
orld Health  Organization  action  plan.8 Continuous  moni-
oring of  the  results  obtained  will  also  be  needed  in  order
o ensure  that  the  plans  adopted  are  effective.
I  conclude  with  the  same  quote  from  Poulter  et  al.9 used
y the  authors:  ‘‘It  therefore  seems  that  the  focus  of  debate
hould not  be  whether  these  modifications  should  be  made,
ut how  best  to  achieve  them.’’onflicts of interest
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